secretrol

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2010 (NCT01129713)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • secretrol

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01905202Phase 1Apr 1, 2013Department of Veteran Affairs, Effexus Pharmaceutical
NCT02210494Phase 1Apr 1, 2013Effexus Pharmaceutical
NCT01129713Phase 1/Phase 2 (Phase 2)May 1, 2010Department of Veteran Affairs, Effexus Pharmaceutical
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Effexus PharmaceuticalFor profit3322010
Department of Veteran AffairsGovernment2022010
2 organizations
Page 1 / 1